Stockscreener 앱 받기
3.54
1.67%
-0.06
시간 외 거래:
3.55
0.010
+0.28%
Oncology Institute Inc 주식(TOI)의 최신 뉴스
The Oncology Institute, Inc. (NASDAQ:TOI) Q4 2025 Earnings Call Transcript - Insider Monkey
Oncology Institute Earnings Call Signals Profitable Shift - The Globe and Mail
Oncology Institute (TOI) CMO logs RSU tax-cover share sale on Form 4 - Stock Titan
Aug Catalysts: What is The Oncology Institute Inc Equity Warrants revenue forecast2026 Earnings Surprises & Technical Analysis for Trade Confirmation - baoquankhu1.vn
Oncology Institute (NASDAQ:TOI) Major Shareholder Acquires $767,960.00 in Stock - MarketBeat
Insider Buying: Oncology Institute (NASDAQ:TOI) Major Shareholder Acquires 60,985 Shares of Stock - MarketBeat
Oncology Institute (NASDAQ:TOI) Major Shareholder Acquires $256,500.00 in Stock - MarketBeat
Chernett Jorey buys oncology institute (TOI) shares worth $1.2m - Investing.com
Oncology Institute Insider Acquires Nearly 399K Shares - TradingView
Major holder boosts stake as Oncology Institute (TOI) insider buys shares - Stock Titan
The Oncology Institute: First Profitable Quarter & 2026 Outlook | 2025 ResultsNews and Statistics - IndexBox
New Highs: Whats the analyst consensus on The Oncology Institute IncGap Up & Safe Entry Zone Identification - baoquankhu1.vn
Insider Buying: Jorey Chernett Acquires Shares in The Oncology I - GuruFocus
Major TOI holder Jorey Chernett reports 9,852,944 Oncology Institute shares - Stock Titan
Chernett Amends 13G; Holds 10.23% of Oncology Institute (TOI) - Stock Titan
Oncology Institute Updates Investors With New Presentation - The Globe and Mail
Why Oncology Institute Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket - Sahm
B. Riley’s Price Target Boost Signals Growth for Oncology Institute - StocksToTrade
Oncology Institute (TOI) Q4 Loss Per Share Improvement Tests Longstanding Profitability Doubts - simplywall.st
The Oncology Institute (NASDAQ: TOI) furnishes updated investor presentation - Stock Titan
Oncology Institute (NASDAQ:TOI) Given New $8.00 Price Target at B. Riley Financial - MarketBeat
The Oncology Institute Reports Strong Q4 Results, Shares Surge - Intellectia AI
Oncology Institute’s Q4 Surprises Stir Investor Interest - StocksToTrade
The Oncology Institute, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
The Oncology Institute, Inc. (TOI) Q4 2025 Earnings Call Transcript Summary - 富途牛牛
The Oncology Institute Inc (TOI) Q4 2025 Earnings Call Highlights: Record Revenue and First ... By GuruFocus - Investing.com Canada
Oncology Institute Q4 Earnings Call Highlights - MarketBeat
Earnings call transcript: Oncology Institute Q4 2025 beats EPS estimates, stock rises - Investing.com South Africa
The Oncology Institute: Value-Based Cancer Care Model, Growth Strategy, and Market Expansion Overview 32 - Minichart
Oncology Institute (NASDAQ:TOI) Issues Earnings Results - MarketBeat
Oncology Institute 2025 10-K: $502.7M Revenue, $(0.54) EPS - TradingView
The Oncology Institute (TOI) Stock Rises on Q4 2025 Earnings - Quiver Quantitative
The Oncology Institute Reports Fourth Quarter and Full Year 2025 Financial Results and Guidance for 2026 - The Manila Times
The Oncology Institute Reports Fourth Quarter and Full Year 2025 Financial Results and Guidance ... - Bluefield Daily Telegraph
The Oncology Institute, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025 - marketscreener.com
Oncology Institute Q4 2025 Earnings Call Transcript - MarketBeat
Oncology Institute Inc expected to post a loss of 9 cents a shareEarnings Preview - TradingView
Analysts Are Bullish on Top Healthcare Stocks: Caribou Biosciences (CRBU), Oncology Institute (TOI) - The Globe and Mail
TOI: BTIG Reiterates Buy Rating, Maintains $7 Price Target | TOI Stock News - GuruFocus
Oncology Institute (NASDAQ:TOI) Receives "Buy" Rating from Needham & Company LLC - MarketBeat
Oncology Institute's (TOI) Buy Rating Reaffirmed at BTIG Research - MarketBeat
Oncology Institute (TOI) Projected to Post Quarterly Earnings on Thursday - MarketBeat
Aug Momentum: Should you avoid The Oncology Institute Inc stock right now2025 Buyback Activity & Real-Time Buy Zone Alerts - baoquankhu1.vn
Risk Report: What is The Oncology Institute Inc Equity Warrants revenue forecastVolume Spike & Expert Verified Movement Alerts - baoquankhu1.vn
Risk Report: What analysts say about The Oncology Institute Inc stockEntry Point & Daily Profit Maximizing Trade Tips - baoquankhu1.vn
Street Watch: What are the risks of holding The Oncology Institute Inc Equity WarrantJuly 2025 Selloffs & Weekly Watchlist for Hot Stocks - baoquankhu1.vn
Fennec Pharmaceuticals Announces Clinical Research Collaboration with Tampa General Hospital Cancer Institute - The Manila Times
Comparing Sera Prognostics (NASDAQ:SERA) & Oncology Institute (NASDAQ:TOI) - Defense World
The Oncology Institute Announces Fourth Quarter and Full Year 2025 Earnings Release Date and Conference Call - The Manila Times
March 12: The Oncology Institute 2025 results and investor call - Stock Titan
The Oncology Institute to Participate in Multiple Healthcare Investor Conferences in March - The Manila Times
Risk Report: What is The Oncology Institute Inc Equity Warrants market position2025 Trade Ideas & AI Powered Buy/Sell Recommendations - baoquankhu1.vn
Aug Decliners: Is The Oncology Institute Inc impacted by rising ratesEarnings Growth Report & Safe Entry Point Identification - baoquankhu1.vn
The Oncology Institute appoints Kim Tzoumakas to board By Investing.com - Investing.com India
The Oncology Institute appoints Kim Tzoumakas to board - Investing.com Australia
Oncology Institute Adds Independent Director to Board - TipRanks
Kim Tzoumakas joins The Oncology Institute (NASDAQ: TOI) board - Stock Titan
Buyout Rumor: Is The Oncology Institute Inc impacted by rising ratesQuarterly Trade Summary & AI Driven Stock Reports - baoquankhu1.vn
The Oncology Institute Appoints Kim Tzoumakas to Board of Directors - Bitget
1.79%
0.42%
자본화:
|
볼륨(24시간):